EP1545318A1 - Gewebe- und flüssigkeitsentnahmevorrichtung - Google Patents
Gewebe- und flüssigkeitsentnahmevorrichtungInfo
- Publication number
- EP1545318A1 EP1545318A1 EP03771980A EP03771980A EP1545318A1 EP 1545318 A1 EP1545318 A1 EP 1545318A1 EP 03771980 A EP03771980 A EP 03771980A EP 03771980 A EP03771980 A EP 03771980A EP 1545318 A1 EP1545318 A1 EP 1545318A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- instrument
- chamber
- tissue
- sample
- sampling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005070 sampling Methods 0.000 title claims abstract description 160
- 239000012530 fluid Substances 0.000 title claims description 24
- 238000000034 method Methods 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 21
- 238000005520 cutting process Methods 0.000 claims description 18
- 238000003384 imaging method Methods 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000000151 deposition Methods 0.000 claims description 4
- 238000003780 insertion Methods 0.000 abstract description 14
- 230000037431 insertion Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 description 50
- 238000001574 biopsy Methods 0.000 description 11
- 239000000758 substrate Substances 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000004621 biodegradable polymer Substances 0.000 description 4
- 229920002988 biodegradable polymer Polymers 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000005459 micromachining Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012864 cross contamination Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- -1 but not limited to Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000000427 thin-film deposition Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
- A61B10/0275—Pointed or sharp biopsy instruments means for severing sample with sample notch, e.g. on the side of inner stylet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0283—Pointed or sharp biopsy instruments with vacuum aspiration, e.g. caused by retractable plunger or by connected syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/06—Biopsy forceps, e.g. with cup-shaped jaws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B2010/0225—Instruments for taking cell samples or for biopsy for taking multiple samples
Definitions
- the invention is related to medical instrumentation, and more particularly to the rapid, minimally invasive collection of multiple tissue and fluid samples.
- Fluid and tissue sampling is used in a number of fields, including gastroenterology, cardiology, oncology, radiology, opthamology, histology, neurology and neurosurgery, internal medicine, and renal specialties. Fluid and tissue samples are necessary for a number of purposes in the medical arena, including in the performance of biopsies, or the removal of tissue samples. Removed tissue from a patient is often used in diagnosis of, for example, a variety of diseases. Often, to make an accurate diagnosis, a number of tissue samples are necessary, as a single tissue sample can fail to represent the entirety of the area, organ, or lesion from which the sample is extracted. Taking a plurality of samples can be not only time consuming, but it can expose the patient to additional and repeated discomfort.
- Tissue samples are extracted from a patient according to a variety of devices, including manually or automatically controlled needle devices, cutting jaw devices, and with catheters having cutting devices disposed on one end, for example. It is desirable to extract a number of tissue samples in a minimally invasive manner.
- the invention provides apparatus and methods for collecting multiple tissue samples and fluid samples in a rapid and substantially minimally invasive manner.
- Microminiature manufacturing technologies are used to produce a biopsy and/or fluid sampling device.
- a sampling platform or apparatus such as a biopsy catheter, includes multiple sampling devices that can take many samples without the withdrawal and reinsertion of multiple catheters.
- the multiple sampling devices are positioned along the outer diameter of the shaft portion of a single catheter or other device, and samples are collected and stored in respective chambers of the sampling devices, alleviating the need to transport the samples to distal locations.
- the invention features an instrument for removing a tissue sample from a subject containing a housing, which contains a plurality of independently-controlled tissue sampling devices, each of the devices containing an isolated chamber.
- isolated is meant that the chamber is physically and spatially separated from another chamber.
- the chamber is closed to an interior lumen of the housing. The lumen may be used to provide actuation to the sampling devices.
- tissue sample is removed from an anatomical site adjacent to the chamber, the chamber is sealed.
- Each chamber is integral to the instrument and acts as a self- contained storage unit, i.e., tissue is not transported to an off-site storage compartment, but remains in the chamber until the device is removed from the subject.
- the volume of the chamber is preferably less than 1.2 cubic millimeters, e.g., the volume ranges from 0.001 to 1 cubic millimeters. In preferred embodiments the volume is 0.005, 0.01, 0.05, 0.1, 0.5, 0.75 cubic millimeters.
- the housing in which the sampling devices are located is hollow or solid.
- the housing contains an interior lumen.
- the lumen optionally contains a deployment control element for deploying one or more of the sampling devices.
- the sampling devices are deployed by contacting the device with an actuation signal emitted by the element.
- the deployment control element emits an electrical, optical, pneumatic, hydraulic, RF- transmitted, inductive, magnetic, thermal or sonic signal, which mediates opening of the chamber and/or deployment of the sampling device to obtain a tissue sample from the subject.
- the chamber does not communicate the tissue sample to the interior lumen of the instrument, and once the chamber is sealed, tissue sample is not communicated to the outside or to any other chamber, thereby avoiding cross-contamination between samples and loss of sample in transport to a distal sample storage facility.
- the deployment control device is embedded in or located on an exterior surface of the housing. For example, a wire runs along the outside of the housing and makes contact with each sampling device/chamber assembly. In either configuration, signal is applied to one of more sampling device simultaneously or sequentially to sample tissues from spatially distinct anatomic locations.
- the tissue sampling devices are radially and longitudinally disposed about the instrument such that upon insertion of the instrument into the subject one or more samples are extracted and isolated in the respective chambers of the sampling devices at the site at which removal occurs.
- the tissue sampling devices are positioned in an array along the length of the instrument.
- the tissue sampling devices are fixed in a position along an outside diameter of an exterior face of the instrument.
- Tissue samples are removed from a bodily tissue using a variety of methods such as scraping or cutting using a jaw or knife mechanism.
- each sampling device optionally contains a set of jaws activated by an expandable volume to mechanically actuate and collect a sample.
- the tissue sampling devices include vacuum sampling chambers, which pull tissue into the chamber.
- the vacuum sampling chambers are characterized by a pressure differential, e.g., a lower pressure, compared to surrounding tissues.
- tissue sampling devices includes a mechanical cutting sampling device such as a sleeve containing a knife edge.
- the sleeve is located exterior to the chambers and is slidably disposed over the housing.
- the sleeve optionally includes a sealing element. Following cutting of a tissue sample and deposition of the sample in the chamber, the sleeve seals the chamber, e.g., by mechanical closure or application of heat to a bonding material.
- Each sampling device in the plurality contains a chamber with a cover, which is closed by means of a bonding material. Opening and closing of the chamber is controlled by application of a vacuum or other force that compromises the integrity of the bonding material.
- the cover is a single unit or contains two sides, which meet and close the chamber by means of bonding material such as an adhesive or a conductive polymer. The vacuum draws tissue into the chamber as the bonding material separates causing a separation of the two sides of the cover.
- the chamber is comprised of at least one of the group consisting of silicon, biodegradable polymer, metal, and a metal alloy.
- the chamber is opened by applying a stress force to the bonding material, which leads to release of the cover.
- a stress force for example, the two sides of the cover separate when a temperature differential is applied to a bonding material connecting the two sides of the cover.
- the cover segment mechanically actuates or opens to allow deposition of a tissue sample upon application of heat to the cover.
- Tissue sampling devices are equipped with a means to extract a sample from a bodily tissue.
- the device contains a three-dimensional scoop to remove tissue from a subject.
- the scoop includes a cutting edge to remove a tissue sample and is pivotally connected to the instrument such that the scoop is pivotally activated to collect the tissue sample and carry the sample as the scoop pivots to a position in which the tissue sample is deposited in a chamber and the scoop is at a resting position.
- the sampling device includes a chamber having a set of jaws disposed therein. The set of jaws extends from the chamber to collect a sample when the set of jaws are mechanically activated. After the sample is obtained, the jaws are retracted, and the sample is deposited and retained in the chamber.
- the chamber further optionally contains a heating element and an expandable volume, and the heating element causes the expandable volume to expand to actively deploy the set of jaws for collection of the sample.
- the invention also includes a method of extracting multiple tissue samples from a subject by inserting into the subject an instrument with a plurality of independently-controlled tissue sampling devices on a housing, each of which contains an isolated chamber.
- the sampling device is contacted with a deployment signal, e.g., an electrical, optical, pneumatic, RJF- transmitted, inductive, magnetic, thermal or sonic signal, which leads to an opening of the chamber.
- a deployment signal e.g., an electrical, optical, pneumatic, RJF- transmitted, inductive, magnetic, thermal or sonic signal
- a tissue sample is removed from an anatomical location adjacent to the chamber and the chamber sealed.
- the tissue extraction element and sealing element are optionally disposed on a sleeve that slides along the length of the instrument.
- the sampling devices are deployed simultaneously or temporally. For example, the sampling devices are deployed sequentially at minute, second, or millisecond intervals.
- the devices are deployed at selected spatial locations together or in sequence. Sampling is controlled in real time by the operator (e.g., based on information from an imaging device regarding the position of the instrument relative to the location of a target tissue) or by means of a predetermined program, e.g., a computer controlled sampling program.
- a predetermined program e.g., a computer controlled sampling program.
- An alternative method includes the steps of inserting the instrument into the subject; heating the plurality of sampling devices (heating causing actuation of a mechanical portion of the plurality of sampling devices, such that a mechanical portion of the sampling devices collects a sample and retains the sample); depositing the sample into a local chamber; and, removing the instrument from the subject. Heating is accomplished by passing electrical current through a portion of the extracting device. Collecting and retaining the sample is accomplished by applying a differential pressure to the local chamber and sucking the sample into the local chamber. Samples are ejected by pressurizing the chamber. Alternatively, collection and retention of the sample is carried out by scooping the sample from the subject by pivoting a scoop from a rest position after heating the scoop.
- collecting and retaining the sample is carried out by expanding a volume of a fluid in a chamber and causing a set of jaws to deploy from the chamber.
- Positioning the instrument and locating target tissues to be sampled is accomplished by a variety of imaging techniques, e.g., fiberoptically or by magnetic resonance imaging (MRI).
- MRI magnetic resonance imaging
- the instrument contains a fiberoptic imaging device.
- Implementations of the invention may include one or more of the following features.
- a plurality of miniature biopsy sampling devices are included on a single catheter.
- a single catheter includes 2, 5, 10, 20, 50, and up to hundreds of miniature sampling devices.
- Still further embodiments of the invention can include less than about 5 miniature biopsy sampling devices on a single catheter, while still other embodiments include greater than about 50 miniature biopsy sampling devices on a single catheter.
- the biopsy sampling devices are positioned along the length of the catheter and on an outside diameter of the catheter.
- the sampling devices remain in position on the outside diameter of the catheter for the duration of insertion of the catheter, collection of the sample, and removal of the sample from the subject.
- Samples are retained in chambers positioned at the site of sampling, and the chambers sealed for removal of the catheter from the subject.
- Sampling devices can create a substantially uniform array along the length of the catheter or other instrumentation.
- the plurality of sampling devices are activated simultaneously such that multiple samples are achieved simultaneously.
- the sampling devices are alternatively activated individually at the operator's discretion.
- the invention permits the analysis and examination of tissue and/or fluid samples. For example, the analysis and examination of smaller tissue and/or fluid samples reduce the amount of tissue required per analytical procedure. Analytic methods, e.g., Polymerase Chain Reaction (PCR), are used to obtain diagnostic information.
- PCR Polymerase Chain Reaction
- the instrumentation and sampling methods described herein permit the replication of genetic data from very small samples, eliminating the need for large tissue samples.
- Embodiments of the invention may provide one or more of the following advantages compared to earlier methods.
- the invention provides devices for use in the sampling of tissue and/or fluids that require fewer sampling procedures to obtain multiple samples. Acquisition of multiple samples is advantageous as it permits a more thorough diagnosis of a particular tissue or physical disorder.
- Sampling is achieved using insertion of a single device into the subject, which permits a rapid removal procedure and reduces the physical damage associated with the repeated insertion and removal of sampling devices, thus reducing the risk of injury to the patient.
- the use of a plurality of sampling devices positioned along the perimeter of the catheter provides multiple samples with similar dimensions.
- the collection of multiple, similarly-sized samples permits the automation of sample analysis, whether chemical, visual, or genomic.
- the collection of multiple samples permits the mapping of tissue spatially with a higher resolution or, alternatively, the sampling of tissue or fluids over time with a more accurate evaluation of bodily fluid condition due to a procedure or introduction of a medication.
- the ability to obtain multiple samples without multiple insertion and removal of sampling devices reduces the sampling time, permitting both shorter procedures and reducing the primary cost of those procedures.
- FIG. 1 is a diagram of a catheter employing multiple sampling devices in one embodiment of the invention
- FIG. 2 is a diagram of a vacuum sampling configuration in one embodiment of the invention
- FIG. 3 is a diagram of a mechanical cutting device used in obtaining samples in one embodiment of the invention.
- FIG. 4A is a diagram of a sampling device in a position before deployment in one embodiment of the invention.
- FIG. 4B is a diagram of the sampling device of FIG. 4A deployed to take a sample in one embodiment of the invention.
- FIG. 4C is a diagram of the sampling device of FIGS. 4A and 4B in a position after deployment in one embodiment of the invention.
- the invention utilizes a number of sampling devices that acquire samples of tissue, fluid or other substances in a rapid manner.
- the invention includes a plurality of miniature sampling devices located on a single sampling platform, such as a catheter.
- Each of the sampling devices is designed to be sufficiently small to permit the deployment of a plurality of sampling devices on the single, larger apparatus or platform, such as a catheter, that is subsequently inserted into the body.
- Embodiments of the invention can be used to obtain samples other than tissue or fluid samples, and with apparatus other than catheters. Still other embodiments are within the scope of the invention.
- a catheter having multiple sampling devices along its length is shown.
- a catheter is a typical instrument used in the medical arena for insertion into a patient for biopsy or other purposes.
- the catheter 50 includes a distal insertion end 52 and sampling devices 54.
- the distal end 52 is a sharp or pointed end that is inserted into the subject requiring removal of tissue or fluid samples.
- the length of the catheter can vary depending on its intended use.
- the catheter employs at least one sampling device 54 that is activated to collect a sample when the catheter is properly inserted. Often, however, collection of a single sample does not provide ample data to make an appropriate diagnosis. Thus, multiple samples are required.
- the catheter 50 includes a plurality of sampling devices 54 to take samples with a single insertion of the catheter 50.
- the sampling devices 54 comprise an array of devices along the length of the catheter 50.
- the catheter 50 can include any number of sampling devices along its length to complete the array.
- the devices 54 are positioned on an outside diameter of the catheter 50. The devices remain in a fixed position on the outside diameter of the catheter for insertion, collection, and removal of the catheter 50. Thus, samples collected by the sampling devices 54 are retained in chambers of the sampling devices directly upon being removed from the subject. This alleviates a need to move the samples to a separate portion of the catheter for storage while further samples are collected. Because multiple samples are collected at multiple sites, the catheter 50 can be a solid member, rather than hollow. The catheter may, but need not comprise an inner lumen into which the samples are deposited.
- sampling devices are used on the catheter 50 to acquire samples.
- Activation of the sampling devices 54 can occur by methods including, but not limited to, hydraulic activation, electrical activation, and pneumatic activation. Activation can occur using a combination of methods as well.
- the sampling devices 54 are activated to extract samples simultaneously or separated in time. In addition, the samples can be taken at varying depths in the organ or diseased area.
- the array of sampling devices 54 is marked to indicate at which level the samples are extracted.
- the sampling devices 54 allow separation and isolation of the samples collected to avoid cross contamination.
- the sampling devices are one of vacuum sampling devices, mechanical cutting sampling devices, and deployed sampling devices, each of which is suitable in an array pattern on a catheter 50.
- a combination of sampling devices 54 is also effective for the removal of multiple samples.
- FIGS. 2-4 three embodiments of the sampling devices of the invention are shown.
- the sampling devices are embedded into the catheter shown in FIG. 1 using micromachining technologies that are used, for example, in the production of polymer micromachines on Kapton subtrates. Numerous micromachining technologies are used for the fabrication of polymer micromachines, including casting, molding, and thin film etching. Each of these technologies is used to produce medical instrumentation having sampling devices positioned on an outer diameter of the instrumentation, generally on a shaft portion.
- sampling devices 54 are fabricated with biodegradable polymers.
- biodegradable polymers allow implementations of this invention with portions that deliberately break off during use, are left within the body, and cause no harm, as they are broken down and absorbed within the body.
- the sampling devices 54 need not be fabricated with biodegradable materials; however, use of biodegradable materials removes the danger associated with portions that break or fail during use.
- the vacuum sampling system 10 includes a chamber 3, a covering material 2 and a bonding material 1.
- the chamber 3 is enclosed on one side by the covering material 2.
- the covering material 2 is bonded by the bonding material 1 on a surface of the covering material 2 that faces an interior of the chamber 3.
- the chamber 3 is manufactured out of an appropriate material, such as a MEMS material, including but not limited to, silicon, a polymer such as PDMS or biodegradable polymer, or a metal or metal alloy such as nickel or nickel alloy.
- the covering material 2 is a polymer.
- the bonding material 1 is a conductive polymer or a metal, including, but not limited to gold.
- the bonding material 1 can be other materials that lose strength when heated. Other suitable materials are also within the scope of the invention.
- the chamber 3 is covered with the covering material 2 while under vacuum. Alternatively, the chamber 3 is covered and then a vacuum is drawn on the chamber 3.
- the covering material 2 separates into two respective parts when the bonding material 1 is removed, causing the two sides of the covering material 2 to separate due to the differential pressure across the material.
- the bonding material 1 is removed or equivalently weakened so that it no longer holds the covering material 2 in place. The bonding material is eliminated in order to collect the tissue or fluid sample into the chamber 3.
- Weakening of the bonding material 1 is accomplished by passing a small current through the bonding material 1, such as heating the bonding material via ohmic heating, which causes it to increase in temperature and therefore lose its strength.
- a small current through the bonding material 1, such as heating the bonding material via ohmic heating, which causes it to increase in temperature and therefore lose its strength.
- thin film deposition technologies such as those used in flexible circuits, deposit conductive vias that provide electrical power to each of the sampling devices.
- the conductive vias, or ducts are positioned on an outside surface of the catheter, rather than inside the catheter body.
- the bonding material 1 does not hold the cover in place due to the differential pressure on each side of the cover, and the cover opens.
- the internal vacuum draws either tissue or fluid from the exterior of the chamber 3 into the chamber 3.
- the differential pressure is equalized as material fills the chamber 3, the chamber 3 having been previously under vacuum.
- the covering material 2 closes, sealing the chamber 3 and holding and isolating a volume of either a fluid or tissue sample.
- the sample is not transported to a different location on the catheter, but is contained in the chamber on the outer diameter of the catheter.
- Vacuum sampling is also achieved through the withdrawal of a piston into the sampling chamber or application of a vacuum to the chamber using micro valves and either an external vacuum pump or vacuum reservoir.
- the covering material 2 in FIG. 2 is contoured to provide tight closure once pressure is equalized on either side of the material.
- the covering material 2 can also be contoured to cut through material drawn into the cavity under vacuum, also isolating the tissue.
- the covering material is designed to separate using an electrical, fluid or other signal without requiring a bonding material.
- the covering material is made conductive in a region where separation is desired. An electrical current is sent through the conducting region, causing it to heat, lose strength, and subsequently separate.
- An additional embodiment of the vacuum sampling device of FIG. 2 includes a single flap configuration, where the flap separates next to a side of the chamber 3 and rotates against an opposite chamber wall subsequent to removal of the bonding material 1.
- the resulting cavity of the chamber 3 is closed by a blade that both cuts the tissue that is then contained in the chamber 3 and seals the chamber 3.
- the configuration illustrated in FIG. 2 is replicated using micromachining technology to produce many such chambers on either a contoured substrate or on a flexible substrate that can be placed over a catheter end. Volumes of such sampling chambers range from as small as about a picoliter or less and as large as about a few hundred microliters or more.
- the chambers are fabricated by molding a polymer over a contoured mold, or by etching a cavity into a substrate, such as silicon, using micromachining. Other suitable methods can be employed, alternatively or additionally.
- Rapid sampling can be accomplished using additional methods and apparatus.
- a sampling device using mechanical cutting is depicted.
- the mechanical cutting devices are places along the length of the catheter, preferably on an outside diameter.
- a small, sharp, and contoured shape cuts tissue or scoops out tissue when the external surface of the biopsy device is placed against the tissue.
- the shape of the cutting device is in the form of a curved three-dimensional shape or a flat blade.
- the mechanical cutting device is scoop-shaped and both cuts tissue that is drawn into a cavity and subsequently seals that cavity by the nature of the shape and motion of the cutting device.
- the mechanical cutting device 100 includes a substrate 6, a curved three-dimensional scoop 7, a pivot 8, and an edge 9.
- the substrate 6 holds the curved three-dimensional scoop 7 that rotates around the preloaded pivot 8.
- the curved shape edge 9 is of sufficient sharpness to cut through tissue and carry the tissue with the scoop as it rotates clockwise in the direction of arrow 12 and comes to rest against the substrate in a rest position 10.
- a tissue 5 is then held in position by the scoop 7 that is loaded against the substrate 6.
- the scoop is sufficiently large to obtain the required amount of tissue, i.e., less than a cubic millimeter, and can be a volume one hundred times smaller than a cubic millimeter.
- the substrate 6 and scoop 7 may be fabricated of any appropriate material.
- the substrate 6 is fabricated from a number of suitable materials, including but not limited to a ceramic, metallic, or polymeric composition.
- the preloaded three-dimensional scoop 7 is fabricated from a number of suitable materials, including but not limited to a ceramic, metallic, or polymeric composition.
- the pivot 8 is a torsional shaft that is preloaded into its cavity by moving the scoop 7 manually into the cavity and applying a heat sensitive, conductive bonding material. The scoop 7 is released by applying a current to the bonding material. The current applied to the bonding material releases the scoop 7 and captures a tissue sample 5. Again, conductive vias can be deposited to provide electrical power to each of the sampling devices.
- Actuation technologies for the pivot 8 include stored mechanical energy released by a heat or electrically actuated latching device.
- the electrical ducts or wires used to provide heat to actuate the device can be located on an outside surface of the catheter, rather than on an inside tunnel of the catheter.
- Other embodiments of the invention include additional actuation technologies such as, for example, shape memory alloys.
- the sample is advantageously contained in the scoop at the locale in which the sample is acquired. The sample is not transported, but is kept isolated until the catheter is removed from the subject.
- a further embodiment of the invention is a sampling device that includes a miniature set of jaws that deploys from a chamber, seizes a portion of tissue and withdraws into the chamber to retain the tissue sample.
- a deployed sampling device is shown.
- a deployed sampling device 200 includes a set of sampling jaws 201, a cover 202, an expandable volume 204, a heating element 206, a chamber 208, an actuation piston 210, and a filled chamber 212.
- the chamber encloses the sampling jaws 201, the cover 202, the expandable volume 204, the heating element 206, the filled chamber 212 and the actuation piston 210.
- the jaws 201 are positioned in an upper portion of the chamber 208, above the position of the actuation piston 210.
- the actuation piston 210 is positioned above the expandable volume 204, and the expandable volume contains the heating element 206.
- the filled chamber 212 further includes a second heating element, and is positioned in a top side portion of the chamber 208.
- the expandable volume 204 can be expanded by heating a fluid within the chamber 208 with the heating element 206, causing the jaws 201 to extend from the chamber 208, penetrating through the cover 202 and surrounding a tissue sample 220.
- the expandable volume is either air that is heated or liquid that is pressurized by a central lumen in the catheter connected to each of the deploying sampling devices 200.
- the expandable volume can be heated electrically, and the electrical wires are positioned on an outside surface of the catheter, obviating the need to have an inner lumen.
- the expandable volume 204 can be a fraction of a cubic millimeter, for example, from 0.001 to 1 cubic millimeter.
- a second, annular, filled chamber 212 with a heating element 206 expands to close the jaws 201 and causes them to retract, holding the tissue sample 220 for subsequent examination, as shown in FIG. 4C.
- the filled chamber 212 causes pressure to be placed on an outside surface of the extended jaws, such that the jaws return to a position within the chamber.
- a filled chamber 212 is positioned such that contact is made with each of the jaws 201.
- the jaws 201 by design, naturally sit within the cavity 208, and are deployed by an internal pressure within the expandable volume 204. When the pressure within the volume decreases, for example by cooling, the jaws 201 retract back within the chamber 208 holding a tissue sample 220.
- Other embodiments of the invention include additional methods of retracting the jaws into the chamber.
- the sample is contained in the jaws 201 within the chamber 212 for the duration of sampling and until the catheter is removed from the subject.
- Other devices that are deployed from a position along the diameter of the catheter are envisioned and effectively draw a sample into the chamber for containment.
- Embodiments of the invention describe individual sampling techniques and devices wherein mechanisms for collecting samples of tissue or fluids are activated, generally by heat or electricity. Samples are collected upon insertion of a catheter having a plurality of sampling devices along its length. In certain embodiments of the invention, sampling devices can be placed in a linear array along a biopsy device and then deployed simultaneously to map the variation of tissue in a given line or direction. Multiple linear samples can be taken to evaluate the extent of change of tissue characteristics, for example, the extent of tumor growth.
- the catheter is a solid body having the sampling devices positioned, or essentially carved out, of its diameter. Wires and other electrical devices are attached on the outside surface of the catheter, rather than in an inner lumen.
- sampling devices can also be placed on a movable platform that places the sampling devices at the same location, such as the tip, on the larger insertion apparatus or platform, such as a catheter.
- This movable platform can be a flexible plastic belt that can be translated around a catheter sampling tip. This permits the operator of the insertion apparatus or platform to position the sampling devices at the same point of the insertion apparatus or platform each time.
- the catheter sampling tip can hold an array of sampling devices on the same surface depending on the size of the catheter sampling tip and the sampling devices.
- An operator of the biopsy or sampling apparatus or platform can then take multiple samples at effectively the same position on the apparatus or platform.
- sampling device permits the addition of fiberoptic imaging to view the actual sampling location, as well as capturing visual images of each sampling site.
- Sampling devices for example, can be located around a central fiber optic imaging lens.
- Devices according to the invention also provide for discharge of the fluid and/or tissue samples when the catheter has been removed from the subject being tested.
- the vacuum sampling devices permit ejection of samples by pressurization of the chamber or by drawing a vacuum across the chamber.
- the cutting sample devices can be reversed mechanically.
- the deployed sampling devices can release the sample by re-pressurizing the deployment volume to re-deploy the sampling jaws.
- devices according to the invention reduce the amount of cross contamination of samples.
- the samples are individually contained in the respective chambers of the sampling devices. This increases the assurance that a given sample removed from a specific sampling device is uncontaminated by other samples.
- devices according to the invention permit an application of drug delivery.
- vacuum sampling devices can be reversed by including a frangible or separating membrane that can separate under pressure, ejecting internal contents.
- the advantages of this embodiment include, for example, providing sufficient pressure to more effectively penetrate any coating formed on the surfaces as well as provide a more vigorous release of medication.
- Applications of this embodiment include placing, for example, these drug delivery structures on catheters to provide measured release of marking fluid or medications that require very accurate placement.
- multiple drugs can be included on the same device, permitting simple and rapid, situation-dependent, delivery of medication.
- a sampling device can be implemented in a standalone version.
- the sampling device can be implanted or swallowed, and samples may be taken at defined time periods.
- body or digestive system chemistry or environments can be sampled over time.
- the standalone product can have a small internal powered control circuit that defines the time spacing or cycle of the different sampling events.
- sampling devices can have dissolvable or passive, unpowered actuation that actuate at different times without requiring a source of internal energy or power. Drug kinetics can be monitored, digestive systems evaluated, and various physiological quantities can be monitored. Such an invention provides previously unavailable diagnostic information or information that would be difficult to collect and/or be particularly uncomfortable to the patient otherwise.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Sampling And Sample Adjustment (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Surgical Instruments (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39896302P | 2002-07-26 | 2002-07-26 | |
US398963P | 2002-07-26 | ||
PCT/US2003/023551 WO2004010874A1 (en) | 2002-07-26 | 2003-07-28 | Tissue and fluid sampling device |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1545318A1 true EP1545318A1 (de) | 2005-06-29 |
EP1545318B1 EP1545318B1 (de) | 2008-02-13 |
Family
ID=31188525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03771980A Expired - Lifetime EP1545318B1 (de) | 2002-07-26 | 2003-07-28 | Gewebe- und flüssigkeitsentnahmevorrichtung |
Country Status (7)
Country | Link |
---|---|
US (1) | US7740595B2 (de) |
EP (1) | EP1545318B1 (de) |
AT (1) | ATE385741T1 (de) |
AU (1) | AU2003254224A1 (de) |
CA (1) | CA2497282A1 (de) |
DE (1) | DE60319105T2 (de) |
WO (1) | WO2004010874A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9381001B2 (en) | 2007-10-25 | 2016-07-05 | Epitome Pharmaceuticals Limited | Tissue splitting biopsy needle |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITCE990004A1 (it) * | 1999-10-25 | 2000-01-25 | Mario Immacolato Paternuosto | Valve per pinza da biopsia in endoscopia digestiva |
US6986748B2 (en) * | 2002-08-15 | 2006-01-17 | Scimed Life Systems, Inc. | Multiple biopsy apparatus and related method of use |
US7588545B2 (en) | 2003-09-10 | 2009-09-15 | Boston Scientific Scimed, Inc. | Forceps and collection assembly with accompanying mechanisms and related methods of use |
US7942896B2 (en) * | 2003-11-25 | 2011-05-17 | Scimed Life Systems, Inc. | Forceps and collection assembly and related methods of use and manufacture |
US7819822B2 (en) * | 2004-03-06 | 2010-10-26 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
ES2572775T3 (es) | 2004-03-06 | 2016-06-02 | F. Hoffmann-La Roche Ag | Dispositivo para la extracción de líquidos corporales |
US7762960B2 (en) | 2005-05-13 | 2010-07-27 | Boston Scientific Scimed, Inc. | Biopsy forceps assemblies |
GB0510801D0 (en) | 2005-05-26 | 2005-06-29 | Pa Knowledge Ltd | Catheter |
GB0800981D0 (en) | 2008-01-18 | 2008-02-27 | Plaque Attack Ltd | Catheter |
ES2369472T3 (es) * | 2008-02-26 | 2011-12-01 | Biostems Ltd. | Dispositivo de investigación micro-invasiva en vivo que comprende una guía metálica. |
WO2013155557A1 (en) * | 2012-04-16 | 2013-10-24 | The University Of Queensland | A microbiopsy device |
US8491495B1 (en) * | 2012-11-16 | 2013-07-23 | L. Zane Shuck | Human intestinal tract research and diagnostic system to evaluate patients and advance medical science and bioengineering and to determine processes in the gut and causes of diseases |
US9215997B2 (en) * | 2012-11-16 | 2015-12-22 | L. Zane Shuck | In vivo technology system for human gut research, diagnostics and treatment |
US8915863B2 (en) * | 2012-11-16 | 2014-12-23 | L. Zane Shuck | In vivo device and method for researching GI tract processes, microbes, and variables associated with illnesses and diseases |
US8926526B2 (en) * | 2012-11-30 | 2015-01-06 | L. Zane Shuck | Patient in vivo gut diagnostic and treatment tool |
US20160095584A1 (en) * | 2014-10-01 | 2016-04-07 | Boston Scientific Scimed, Inc. | Endoscopic needle with rotary jaw for lateral acquisition |
CN105261052B (zh) * | 2015-11-03 | 2018-09-18 | 沈阳东软医疗系统有限公司 | 管腔图像展开绘制方法及装置 |
CN108186059B (zh) * | 2018-03-13 | 2020-07-28 | 湖州市妇幼保健院 | 一种胃肠镜活检摘取装置 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4305406A (en) * | 1980-06-13 | 1981-12-15 | Becton, Dickinson And Company | Needle assemblies with anti-backflow features |
WO1992011816A2 (en) * | 1991-01-09 | 1992-07-23 | Endomedix Corporation | Method and device for intracorporeal liquidization of tissue and/or intracorporeal fragmentation of calculi during endoscopic surgical procedures |
JPH05208014A (ja) * | 1991-04-10 | 1993-08-20 | Olympus Optical Co Ltd | 処置具 |
US5285795A (en) * | 1991-09-12 | 1994-02-15 | Surgical Dynamics, Inc. | Percutaneous discectomy system having a bendable discectomy probe and a steerable cannula |
WO1993022971A1 (en) * | 1992-05-11 | 1993-11-25 | Boston Scientific Corporation | Multiple needle biopsy instrument |
US5295990A (en) * | 1992-09-11 | 1994-03-22 | Levin John M | Tissue sampling and removal device |
AU6444094A (en) | 1993-03-08 | 1994-09-26 | Kvm Technologies, Inc. | Fluid sample receptacle |
JP3607702B2 (ja) | 1993-05-17 | 2005-01-05 | ボストン・サイエンティフィック・コーポレーション | 多数バイオプシー試料採取器具 |
EP0722286B1 (de) | 1993-09-20 | 2002-08-21 | Boston Scientific Corporation | Vorrichtung zur wiederholten probenentnahme |
US5840044A (en) | 1993-09-30 | 1998-11-24 | Boston Scientific Corporation | Multiple biopsy sampling forceps |
US5871453A (en) | 1994-02-08 | 1999-02-16 | Boston Scientific Corporation | Moveable sample tube multiple biopsy sampling device |
US5649547A (en) | 1994-03-24 | 1997-07-22 | Biopsys Medical, Inc. | Methods and devices for automated biopsy and collection of soft tissue |
US5526822A (en) * | 1994-03-24 | 1996-06-18 | Biopsys Medical, Inc. | Method and apparatus for automated biopsy and collection of soft tissue |
US5531756A (en) * | 1994-08-02 | 1996-07-02 | Larose; Daniel J. | Arthroscopic surgical punch |
US5595185A (en) | 1994-08-11 | 1997-01-21 | N.M.B. Medical Applications Ltd. | Single puncture multi-biopsy gun |
US5794626A (en) * | 1994-08-18 | 1998-08-18 | Kieturakis; Maciej J. | Excisional stereotactic apparatus |
US5562102A (en) | 1994-11-21 | 1996-10-08 | Taylor; Thomas V. | Multiple biopsy device |
BE1009902A3 (nl) * | 1995-12-28 | 1997-10-07 | Janssens Jacques Phillibert | Inrichting voor het nemen van een weefselstaal. |
US5827305A (en) | 1996-01-24 | 1998-10-27 | Gordon; Mark G. | Tissue sampling device |
US5928161A (en) * | 1997-07-03 | 1999-07-27 | The Regents Of The University Of California | Microbiopsy/precision cutting devices |
DE69829974T8 (de) * | 1997-07-24 | 2006-04-27 | Rex Medical, L.P. | Vorrichtung zur brustchirurgie |
AU4058897A (en) | 1997-08-08 | 1999-03-01 | Arthur C. Johnson | Multiple sample biopsy forceps |
US6050955A (en) | 1997-09-19 | 2000-04-18 | United States Surgical Corporation | Biopsy apparatus and method |
US6019733A (en) | 1997-09-19 | 2000-02-01 | United States Surgical Corporation | Biopsy apparatus and method |
US5980468A (en) | 1997-09-22 | 1999-11-09 | Zimmon Scientific Corporation | Apparatus and method for serial collection storage and processing of biopsy specimens |
US6050138A (en) | 1997-10-22 | 2000-04-18 | Exponent, Inc. | System and method for performing bulge testing of films, coatings and/or layers |
CA2307237A1 (en) | 1997-10-23 | 1999-04-29 | The Trustees Of Columbia University In The City Of New York | Multiple bite, multiple specimen endoscopic biopsy forceps |
US6454727B1 (en) * | 1998-03-03 | 2002-09-24 | Senorx, Inc. | Tissue acquisition system and method of use |
US6110129A (en) | 1998-07-13 | 2000-08-29 | Medical Device Technologies, Inc. | Biopsy needle and surgical instrument |
US6440147B1 (en) | 1998-09-03 | 2002-08-27 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
GB9902045D0 (en) * | 1999-01-29 | 1999-03-17 | Univ London | Device for removing surface tissue,in particular for taking biopsies |
US6083150A (en) | 1999-03-12 | 2000-07-04 | C. R. Bard, Inc. | Endoscopic multiple sample biopsy forceps |
SE521675C2 (sv) | 2000-01-24 | 2003-11-25 | Christer Dahlstrand Ab | Anordning för att erhålla ett flertal biopsier i ett gemensamt provtagningsstick |
US6485436B1 (en) | 2000-08-10 | 2002-11-26 | Csaba Truckai | Pressure-assisted biopsy needle apparatus and technique |
US6695787B2 (en) * | 2000-08-25 | 2004-02-24 | Neoseed Technology Llc. | Prostate visualization device and methods of use |
US6419640B1 (en) | 2000-10-03 | 2002-07-16 | Thomas V. Taylor | Multiple-specimen, endoscopic biopsy forceps |
WO2002062229A2 (en) | 2001-02-05 | 2002-08-15 | Tyco Healthcare Group Lp | Biopsy apparatus and method |
WO2002062231A2 (en) | 2001-02-05 | 2002-08-15 | Tyco Healthcare Group Lp | Biopsy apparatus and method |
WO2002062228A1 (en) | 2001-02-05 | 2002-08-15 | Tyco Healthcare Group Lp | Biopsy apparatus and method |
US6530891B2 (en) | 2001-04-02 | 2003-03-11 | Temple University Of The Commonwealth System Of Higher Education | Multiple biopsy device |
US7877133B2 (en) * | 2003-05-23 | 2011-01-25 | Senorx, Inc. | Marker or filler forming fluid |
-
2003
- 2003-07-28 US US10/629,048 patent/US7740595B2/en not_active Expired - Fee Related
- 2003-07-28 AU AU2003254224A patent/AU2003254224A1/en not_active Abandoned
- 2003-07-28 EP EP03771980A patent/EP1545318B1/de not_active Expired - Lifetime
- 2003-07-28 AT AT03771980T patent/ATE385741T1/de not_active IP Right Cessation
- 2003-07-28 WO PCT/US2003/023551 patent/WO2004010874A1/en active IP Right Grant
- 2003-07-28 CA CA002497282A patent/CA2497282A1/en not_active Abandoned
- 2003-07-28 DE DE60319105T patent/DE60319105T2/de not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO2004010874A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9381001B2 (en) | 2007-10-25 | 2016-07-05 | Epitome Pharmaceuticals Limited | Tissue splitting biopsy needle |
Also Published As
Publication number | Publication date |
---|---|
US20040024333A1 (en) | 2004-02-05 |
EP1545318B1 (de) | 2008-02-13 |
CA2497282A1 (en) | 2004-02-05 |
ATE385741T1 (de) | 2008-03-15 |
WO2004010874A1 (en) | 2004-02-05 |
DE60319105D1 (de) | 2008-03-27 |
DE60319105T2 (de) | 2009-02-05 |
AU2003254224A1 (en) | 2004-02-16 |
US7740595B2 (en) | 2010-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7740595B2 (en) | Tissue and fluid sampling device | |
EP2196155B1 (de) | Mit Transportsystem verwendbare Biopsievorrichtung für mehrfache Probennahme mit Einzeleinführung | |
EP3300667B1 (de) | Mikrotom-sezierbarer biopsieträger zur ausrichtung von gewebeproben | |
JP3769288B2 (ja) | 組織サンプルを得るための生検器具 | |
EP1595502B1 (de) | Vorrichtung zur serienweisen Entnahme, Aufbewahrung und Verarbeitung von Biopsie-Proben | |
JP4955681B2 (ja) | 直線駆動装置を有する単一挿入複数サンプリング生検デバイス | |
EP2550927B1 (de) | Fasermarker und intrakorporale Abgabe davon | |
EP1026992A1 (de) | Vorrichtung und verfahren zur biopsie | |
EP1912556B1 (de) | Katheter zur Abnahme von Blut | |
US20080167576A1 (en) | Three-dimensional micro spike and method of manufacturing the same | |
WO2008112145A1 (en) | Tissue sample support and orientation device | |
US8137320B2 (en) | Securement for a surgical site marker and deployment device for same | |
EP3946134B1 (de) | Vorrichtung zur direkten markierung | |
EP3616625B1 (de) | Biopsieanordnung | |
EP4176821A1 (de) | Verfahren und vorrichtung zur entfernung von kerngewebebiopsieproben aus kernsammlern und zur lagerung und vorbereitung von proben für die pathologie | |
US20090124928A1 (en) | Apparatus for Circumferential Suction Step Multibiopsy of the Esophagus or Other Luminal Structure with Serial Collection, Storage and Processing of Biopsy Specimens within a Removable Distal Cassette for In Situ Analysis | |
WO2024086055A1 (en) | Biopsy device with end deployment for marker delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050225 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60319105 Country of ref document: DE Date of ref document: 20080327 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080524 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
ET | Fr: translation filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080513 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080714 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20081114 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080513 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080728 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080728 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080814 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080213 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20100728 Year of fee payment: 8 Ref country code: FR Payment date: 20100805 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20100726 Year of fee payment: 8 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20110728 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20120330 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110801 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120201 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60319105 Country of ref document: DE Effective date: 20120201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110728 |